Status:
RECRUITING
Misoprostol Before Caesarean Section
Lead Sponsor:
Kafrelsheikh University
Conditions:
Misoprostol
Respiratory Distress Syndrome (RDS) of Neonate
Eligibility:
FEMALE
20-35 years
Phase:
PHASE4
Brief Summary
The aim of our study is to evaluate the efficacy of Misoprostol before elective cesarean section in pregnant women with gestational age less than 38 weeks for preventing the occurrence of neonatal res...
Detailed Description
Caesarean section is one of the most common carried out surgical procedures in modern obstetrics. About 18.5 million caesarean section are conducted yearly worldwide, and 21-33% of all caesarean secti...
Eligibility Criteria
Inclusion
- Women with indication for elective caesarean section.
- Age less than 35 years old.
- Gestational age less than 38 weeks.
- Gestational age will be confirmed by certain LMP or reliable early ultrasound measurement of crown-rump length.
- Singleton pregnancy with no major anomalies
Exclusion
- Any obstetric disorders as preeclampsia and diabetes.
- Fetus with oligohydramnios, intrauterine growth restriction.
- Any contraindications to misoprostol like those with previous allergic reaction or hypersensitivity to prostaglandin hemorrhagic disorders, and severe anemia.
- History of more than or equal 2 previous caesarean section.
Key Trial Info
Start Date :
June 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2025
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT06946914
Start Date
June 1 2024
End Date
August 1 2025
Last Update
May 13 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kafr El-sheikh University Hospital
Kafr Ash Shaykh, Egypt, Egypt